FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 89 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $89,000 | -25.8% | 12,915 | 0.0% | 0.00% | – |
| Q1 2022 | $120,000 | -34.8% | 12,915 | 0.0% | 0.00% | – |
| Q4 2021 | $184,000 | -37.8% | 12,915 | +1.1% | 0.00% | -100.0% |
| Q3 2021 | $296,000 | -6.9% | 12,775 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $318,000 | -10.9% | 12,775 | +0.2% | 0.00% | 0.0% |
| Q1 2021 | $357,000 | +47.5% | 12,755 | +84.0% | 0.00% | – |
| Q4 2020 | $242,000 | -2.4% | 6,932 | +39.3% | 0.00% | -100.0% |
| Q3 2020 | $248,000 | – | 4,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 1,268,805 | $8,742,000 | 8.10% |
| Samsara BioCapital, LLC | 1,565,526 | $10,786,000 | 2.88% |
| Deep Track Capital, LP | 4,050,000 | $27,905,000 | 1.83% |
| RA Capital Management | 9,011,651 | $62,090,000 | 1.66% |
| Cormorant Asset Management, LP | 3,172,204 | $21,856,000 | 1.65% |
| ARMISTICE CAPITAL, LLC | 4,736,000 | $32,631,000 | 0.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 94,386 | $650,000 | 0.20% |
| Parkman Healthcare Partners LLC | 78,603 | $542,000 | 0.20% |
| Integral Health Asset Management, LLC | 130,051 | $896,000 | 0.18% |
| Opaleye Management Inc. | 58,700 | $404,000 | 0.18% |